Medtronic’s Q4 fiscal 2023 earnings per share is expected to be $1.56 per Trefis analysis, in line with the consensus estimate. Medtronic’s net income of $1.7 billion in Q3 reflected a 6% fall ...

Medtronic is among the world’s largest makers of medical devices. - Jenn Ackerman for WSJ Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the ...

Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year ...

Medtronic expects the separation of its diabetes business to be immediately profitable and improve margins, as diabetes devices require unique commercial and manufacturing strategies. The company ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating ...

Medtronic's diverse business makes it an attractive option for long-term investors. Sales haven't been great lately for the medical device maker due to supply chain issues. There are multiple ...

Feb 9 (Reuters) - A unit of medical device maker Medtronic plc (MDT.N), opens new tab must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement, a Santa Ana ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than 8,000 global employees and carry a nearly $3 billion portfolio of ...

Medtronic plans to lay off some of its nearly 100,000 employees globally, following through on plans for major cost-cutting announced in February. The medical device company, which has operational ...